Replies to Post #210 onTScan Therapeutics Inc (TCRX)

Replies to post #210 on TScan Therapeutics Inc (TCRX)

Replies to #210 on TScan Therapeutics Inc (TCRX)

12/15/23 12:37 PM

#211 RE: jondoeuk #210

Thanks. Why pts lacking actionable genetic aberrations were tested? No LD? The trial was destined to fail.

12/16/23 2:54 PM

#212 RE: jondoeuk #210

Ignore last message. Looks like TCR T is good for cold tumor like SS. No wonder IMCR engager failed in OV.